田中貴金屬工業投資旨在建立日本醫療風險生態系統的風險投資基金「DMC1號投資事業有限合夥」
Dec 20, 2022 10:00 HKT |  |
|
中国抗体荣获“第七届金港股”评选中“最具价值医药及医疗公司”奖项
Dec 19, 2022 14:57 HKT |  |
|
中國抗體榮獲「第七屆金港股」評選中「最具價值醫藥及醫療公司」獎項
Dec 19, 2022 14:56 HKT | |
|
SinoMab Awarded the "Most Valuable Pharmaceutical and Medical Company" in the Selection of the "7th Hong Kong Golden Stocks Awards"
Dec 19, 2022 14:55 HKT | |
|
覆盖「研发-生产-商业化」的综合性生物制药公司 博安生物H股全球发售
Dec 19, 2022 10:27 HKT |  |
|
覆蓋「研發-生產-商業化」的綜合性生物製藥公司 博安生物H股全球發售
Dec 19, 2022 10:26 HKT | |
|
An Integrated Biopharmaceutical Company Covering "R&D- Production-Commercialization" Boan Biotech's Global Offering of H Shares
Dec 19, 2022 10:25 HKT | |
|
Prenetics收购行动基因 首次公开招股后首宗并购交易 势扩大癌症基因组学之份额
Dec 16, 2022 19:59 HKT |  |
|
Prenetics收購行動基因 首次公開招股後首宗並購交易 勢擴大癌症基因組學之份額
Dec 16, 2022 19:58 HKT | |
|
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics
Dec 16, 2022 19:57 HKT | |
|
数据显示 50% 的新试验位于亚太地区
Dec 16, 2022 07:00 HKT |  |
|
數據顯示 50% 的新試驗位於亞太地區
Dec 16, 2022 07:00 HKT | |
|
자료 보고, 새로운 임상 시험 중 50%의 시험 장소가 아시아 태평양 지역에 위치
Dec 16, 2022 07:00 HKT | |
|
Data Shows 50% of New Trials Have Sites in Asia Pacific
Dec 15, 2022 10:00 HKT | |
|
Sirnaomics宣布STP705用于治疗成人原位鳞状细胞皮肤癌的IIb期临床试验获得积极中期数据
Dec 14, 2022 23:17 HKT | |
|
Sirnaomics宣佈STP705用於治療成人原位鱗狀細胞皮膚癌的IIb期臨床試驗獲得積極中期數據
Dec 14, 2022 23:16 HKT | |
|
Sirnaomics Announces Positive Interim Data from Phase IIb Clinical Trial of STP705 in Adults with Cutaneous Squamous Cell Carcinoma In Situ
Dec 14, 2022 23:15 HKT | |
|
Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding
Dec 14, 2022 21:45 HKT |  |
|
Sirnaomics执行董事戴晓畅博士将于2022年度香港国际生物科技展上发表主题演讲
Dec 14, 2022 11:58 HKT | |
|
Sirnaomics執行董事戴曉暢博士將於2022年度香港國際生物科技展上發表主題演講
Dec 14, 2022 11:57 HKT | |
|